Latest Press Releases
View all
TimeHeadline
13m agoUltra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
13m agoGridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
13m agoRush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend
14m agoEVgo to Report First Quarter 2026 Results on May 5
14m agoSound Financial Bancorp, Inc. Q1 2026 Results
Gossamer Bio Inc logo

Gossamer Bio Inc

About

Gossamer Bio Inc (NASDAQ:GOSS) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 17 2026
Gossamer Bio Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update
Feb 23 2026
Gossamer Bio Announces Topline Results from the Phase 3 PROSERA Study Evaluating Seralutinib in Pulmonary Arterial Hypertension
Jan 9 2026
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 24 2025
Gossamer Bio to Participate in Upcoming Investor Conferences
Nov 5 2025
Gossamer Bio Announces Third Quarter 2025 Financial Results and Provides Business Update

Financials

Revenue
$48.47 M
Market Cap
$86.84 M
EPS
-0.75

Community Chat

Ask AI

6ix6ixAIEvents